MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ABUS has $277,164K in assets. $16,987K in debts. $23,706K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
5426.27%
Quick Ratio
5426.27%
Cash Ratio
464.37%
Debt to Asset Ratio
6.13%
Unit: Thousand (K) dollars
Assets Breakdown
    • License receivable from genevant
    • Investments in marketable short-...
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Issued and outstanding 196,947,7...
    • Deficit
    • Additional paid-in capital
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
23,706 18,008 22,408 37,412
Investments in marketable securities, current
-73,463 --
Investments in marketable short-term securities
71,520 -71,294 60,676
Accounts receivable
1,312 1,447 905 1,025
License receivable from genevant
178,741 ---
Prepaid expenses and other current assets
1,732 1,538 2,835 4,006
Total current assets
277,011 94,456 97,442 103,119
Property and equipment, net of accumulated depreciation and impairment of 224 (december 31, 2025 213)
22 32 137 148
Right of use asset
-0 0 0
Other non-current assets
131 130 131 0
Total assets
277,164 94,618 97,710 103,267
Accounts payable and accrued liabilities
4,474 5,459 4,653 4,508
Deferred license revenue, current
-0 0 0
Lease liability, current
631 547 531 514
Total current liabilities
5,105 6,006 5,184 5,022
Liability related to sale of future royalties
3,278 3,442 3,684 3,910
Deferred license revenue, non-current
-0 0 0
Contingent consideration
8,604 8,395 11,052 10,784
Lease liability, non-current
0 199 391 575
Total liabilities
16,987 18,042 20,311 20,291
Issued and outstanding 196,947,757 (december 31, 2025 192,531,225)
1,444,494 1,421,429 1,418,560 1,417,110
Additional paid-in capital
74,256 83,318 83,285 82,628
Deficit
-1,210,378 -1,380,073 -1,376,317 -1,368,575
Accumulated other comprehensive loss
-48,195 -48,098 -48,129 -48,187
Total stockholders equity
260,177 76,576 77,399 82,976
Total liabilities and stockholders equity
277,164 94,618 97,710 103,267
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

License receivable fromgenevant$178,741K Investments in marketableshort-term securities$71,520K Cash and cashequivalents$23,706K Prepaid expenses andother current assets$1,732K Accounts receivable$1,312K Total current assets$277,011K Other non-currentassets$131K Property and equipment,net of accumulated...$22K Total assets$277,164K Total liabilities andstockholders equity$277,164K Total stockholdersequity$260,177K Total liabilities$16,987K Deficit-$1,210,378K Accumulated othercomprehensive loss-$48,195K Issued and outstanding196,947,757 (december 31,...$1,444,494K Contingent consideration$8,604K Total currentliabilities$5,105K Liability related to saleof future...$3,278K Additional paid-in capital$74,256K Accounts payable andaccrued liabilities$4,474K Lease liability,current$631K

Arbutus Biopharma Corp (ABUS)

Arbutus Biopharma Corp (ABUS)